For too long, we have viewed Parkinson’s through a reductionist lens—a simple shortage of dopamine in a specific corner of the brain. However we can no longer deny that this disease is far more complex than a single chemical deficit could explain.
Yesterday’s paper in Nature from Profs Jianxun Ren, Nico Dosenbach, Hesheng Liu and colleagues, identifies the Somato-Cognitive Action Network (SCAN) as an intriguing structural “map” for what some have long suspected: Parkinson’s is not just a motor disorder; it is a systemic failure of communication.
Beyond the Dopamine Deficit
This discovery fits nicely into the framework of oscillopathies—the idea that neurological disorders are the result of network disturbances. As explored in What is an Oscillopathy?, the brain relies on precise rhythmic oscillations to transfer information. When these rhythms fall out of sync, the system breaks down.
The Nature study reveals that in Parkinson’s, the SCAN—a bridge between our thoughts and our actions—becomes “hyperconnected” to the subcortex. In the language of oscillopathies, this is a state of pathological synchrony. The network is essentially “stuck” in a high-volume broadcast, creating neurological static that prevents the fluid transition from intention to movement.
Calming the Network
Our current therapies—Levodopa, DBS, and Focused Ultrasound—are effective not just because they “fix” a local site, but because they act as filters for this noise. As several experts noted in a survey on oscillopathies, the future of treatment lies in modulating these broken circuits rather than just flooding the brain with chemicals.
The Nature data shows that when we target the SCAN specifically we can see up to a doubling of symptom relief. This is potentially moving the field away from using these therapies as a “blunt instrument” and toward Precision Neurology. By identifying the specific nodes of the SCAN in each patient, we can go beyond the “one-size-fits-all” model that has stalled progress for decades.
A New Horizon
If Parkinson’s is truly a “SCAN-opthy,” then our goal changes. We are no longer just chasing dopamine; we are tuning the instrument. We are learning to quiet the hyperconnectivity and restore the natural rhythms of the brain.
It is a reminder that while science is an imperfect process, every new map we draw brings us one step closer to a tomorrow where the bridge between thought and action is much smoother and patients get treatments tuned to their individual disorder.
Thanks Benjamin for sharing this hopeful news. I appreciate the work you have done in order to share the information you have found.